Genomic Characterization of <i>ERBB2</i>-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine

Sebastian Mondaca, Pedram Razavi, Chongrui Xu, Michael Offin, Mackenzie Myers, Maurizio Scaltriti, Jaclyn F. Hechtman, Mikaela Bradley, Eileen M. O’Reilly, Michael F. Berger, David B. Solit, Bob T. Li, Ghassan K. Abou-Alfa

Open source

DOI: 10.1200/po.19.00223
Published: 2019-12
Container: JCO Precision Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/po.19.00223,
  title = {Genomic Characterization of <i>ERBB2</i>-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine},
  author = {Sebastian Mondaca and Pedram Razavi and Chongrui Xu and Michael Offin and Mackenzie Myers and Maurizio Scaltriti and Jaclyn F. Hechtman and Mikaela Bradley and Eileen M. O’Reilly and Michael F. Berger and David B. Solit and Bob T. Li and Ghassan K. Abou-Alfa},
  year = {2019},
  journal = {JCO Precision Oncology},
  doi = {10.1200/po.19.00223},
  url = {https://doi.org/10.1200/po.19.00223}
}

RIS

TY  - JOUR
TI  - Genomic Characterization of <i>ERBB2</i>-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine
AU  - Sebastian Mondaca
AU  - Pedram Razavi
AU  - Chongrui Xu
AU  - Michael Offin
AU  - Mackenzie Myers
AU  - Maurizio Scaltriti
AU  - Jaclyn F. Hechtman
AU  - Mikaela Bradley
AU  - Eileen M. O’Reilly
AU  - Michael F. Berger
AU  - David B. Solit
AU  - Bob T. Li
AU  - Ghassan K. Abou-Alfa
PY  - 2019
JO  - JCO Precision Oncology
DO  - 10.1200/po.19.00223
UR  - https://doi.org/10.1200/po.19.00223
ER  -

APA

Mondaca, S., Razavi, P., Xu, C., Offin, M., Myers, M., Scaltriti, M., Hechtman, J. F., Bradley, M., O’Reilly, E. M., Berger, M. F., Solit, D. B., Li, B. T., & Abou-Alfa, G. K. (2019). Genomic Characterization of <i>ERBB2</i>-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine. JCO Precision Oncology. https://doi.org/10.1200/po.19.00223

Source records

crossref · retrieved 2026-09-26T17:07:04.629Z